Instauración de anticoagulación en fibrilación auricular subclínica detectada por dispositivo: ¿en qué desenlaces impacta?

Hugo Fernando Fuentes Blanco; Diego Alejandro Malagón Albarracín; Francisco Javier González Perdomo; Michael Ortega Sierra

doi:10.47487/apcyccv.v5i2.365

Authors

Hugo Fernando Fuentes Blanco Departamento de Medicina, Universidad Del Magdalena, Santa Marta, Colombia. https://orcid.org/0009-0007-4647-6089
Diego Alejandro Malagón Albarracín Departamento de Medicina, Universidad Militar Nueva Granada, Bogotá, Colombia. https://orcid.org/0009-0008-1738-596X
Francisco Javier González Perdomo Departamento de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia. https://orcid.org/0009-0006-7696-0632
Michael Ortega Sierra Departamento de Neurocirugía, Universidad Centroccidental Lisandro Alvarado, Barquisimeto, Venezuela; Hospital Central Antonio María Pineda, Barquisimeto, Venezuela. https://orcid.org/0000-0002-3091-9945

DOI:

https://doi.org/10.47487/apcyccv.v5i2.365

Keywords:

Anticoagulants, Atrial Fibrillation

Abstract

No aplica

Downloads

Download data is not yet available.

References

Ballatore A, Matta M, Saglietto A, Desalvo P, Bocchino PP, Gaita F, et al. Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice. Medicina (Kaunas). 2019;55(8):497. doi: 10.3390/medicina55080497.

Boriani G, Gerra L, Mei DA, Bonini N, Vitolo M, Proietti M, et al. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? Eur J Intern Med. 2024;S0953-6205(24)00002-5. doi: 10.1016/j.ejim.2024.01.002.

McIntyre WF, Benz AP, Becher N, Healey JS, Granger CB, Rivard L, et al. Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Circulation. 2024;149(13):981-988. doi: 10.1161/CIRCULATIONAHA.123.067512.

Patel SM, Ruff CT. Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits. Circulation.

;149(13):989-992. doi: 10.1161/CIRCULATIONAHA.123.067919.

Noseworthy PA, Kaufman ES, Chen LY, Chung MK, Elkind MSV, Joglar JA, et al. Subclinical and Device-Detected Atrial Fibrillation:

Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation. 2019;140(25):e944-e963.

doi: 10.1161/CIR.0000000000000740.

Mulder BA, Van Gelder IC, Rienstra M. Device-Detected Atrial Fibrillation. Circulation. 2019;139(22):2513-2515. doi: 10.1161/CIRCULATIONAHA.119.040549.

Kashou AH, Adedinsewo DA, Noseworthy PA. Subclinical Atrial Fibrillation: A Silent Threat with Uncertain Implications. Annu Rev

Med. 2022;73:355-362. doi: 10.1146/annurev-med-042420-105906.

Batista Mendoza G, Giraldo Puentes GA, Rosero Palacios E, Brett Cano PJ, Ramírez Reyes KT, Zapata Valencia CM, et al. Investigación latinoamericana en falla cardiaca: análisis visual y bibliométrico de los últimos 20 años. Arch Peru Cardiol Cir Cardiovasc. 2023;4(4):141-150. doi: 10.47487/apcyccv.v4i4.328.